Degenerative disorders: These often happen with ageing, although there are other factors.

Degenerative disorders: Degenerative disorders are commonly linked to an aging body, though there are other factors.

The compounds of the present invention are useful in the treatment of neurodegenerative disorders including cerebrovascular disorders.

The invention relates to compositions and methods for treating degenerative disorders.

Generally, these degenerative disorders are incurable.

The present invention is further directed to methods for diagnosing degenerative disorders characterized in inappropriate cell proliferation or inappropriate cell death, as well as methods for monitoring the progress of such degenerative disorders.

Adults with Degenerative Cognitive and Linguistic Disorders.

The present invention is based on an in vivo animal model that mimics human cellular and tissue degenerative disorders.

The invention provides methods for treating or preventing bone degenerative disorders.

Ataxia disorders are a group of degenerative disorders that are defined as genetic or sporadic.

The methods and compositions of the present invention find further use in the treatment and/or prevention of ocular disorders, particularly retinal degenerative disorders.

The metalloproteases of the invention have value in the treatment of nerve damage and of degenerative disorders of the nervous system.

The combined composition of the invention may be particularly used for treating calcification related degenerative disorders, specifically, vascular and valvular disorders.

The damage from degenerative disorders usually is not repairable.

Spondylolisthesis is one of the related conditions of degenerative disk disorder.